Active, not recruiting

2

309

RoW

TBAJ-876, Pretomanid, PA-824, Dovprela, Linezolid, Zyvox, Bedaquiline, Sirturo, TMC207, HRZE, HR

Global Alliance for TB Drug Development

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis

01/25

06/26

Recruiting

2

90

RoW

BTZ-043, Bedaquiline, SIRTURO®, Delamanid, OPC-67683, Deltyba, Moxifloxacin, Lonxave

Michael Hoelscher, Radboud University Medical Center, University of California, San Francisco, University College, London

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis

08/24

08/24

Recruiting

2

2500

RoW

GSK3036656, BTZ-043, Bedaquiline (B), Delamanid (D), Pretomanid (Pa), Moxifloxacin (M), Linezolid (L), Pyrazinamide (Z), Rifampicin (R), Isoniazid (H), Ethambutol (E)

University College, London, Radboud University Medical Center, London School of Hygiene and Tropical Medicine, University of Oxford, Research Center Borstel, Lygature, TASK Applied Science, Vita-Salute San Raffaele University, Helmholtz Zentrum Munchen, KNCV Tuberculosis Foundation, Critical Path Institute, European Lung Foundation, Instituto de Saude Publica da Universidade do Porto, University of Liverpool, Institut de Recherche Pour le Developpment, University of Hamburg-Eppendorf, University of California, San Francisco, TB Alliance, Find, University of Milano, University of St Andrews, Uppsala University, European Respiratory Society, Tuberculosis Network European Trialsgroup, Janssen, LP, Otsuka Pharmaceutical Development & Commercialization, Inc., German Center for Infection Research, LMU University Hospital Munich, University of Cambridge, GlaxoSmithKline

Pulmonary Tuberculosis

02/27

08/27